Medical

🔬 Epigenetic Reprogramming Enters Human Trials — The FDA cleared the first partial de-aging trial using OSK reprogramming factors, targeting vision restoration in glaucoma patients. 🧠 Diet and APOE Genetics Collide — Higher meat intake correlated with slower cognitive decline in older adults carrying Alzheimer's risk genes, upending common dietary assumptions. 🤖 NVIDIA and Lilly Bet $1 Billion on AI Drug Discovery — A landmark co-innovation lab in San Francisco will embed AI engineers alongside biologists to redesign how medicines are discovered. 🦠 Gut Bacteria Act Like Syringes — Common gut microbes can inject proteins directly into human cells, reshaping how researchers understand microbiome-immune crosstalk. 😴 Circadian Fragmentation Doubles Dementia Risk — Weak internal body clocks are now confirmed as a significant, and potentially modifiable, risk factor for dementia.

🔬 Aging is a coordination failure — The 2026 World Congress on Targeting Longevity is reframing aging as a breakdown between biological systems, shifting strategy from single-target drugs to systems medicine. 🤖 AI drug discovery hits clinical scale — Over 173 AI-discovered drug programs are now in human trials with breakthrough Phase I success rates, and new tools can screen millions of compounds in hours. 🫁 Aging lung cells drive respiratory vulnerability — UCSF researchers pinpointed aging fibroblasts as the trigger for the deadly inflammatory overreaction that makes flu and COVID so dangerous in older adults. 🦠 Gut bacteria directly control immunity — Microbes inject proteins into human cells to manipulate immune responses, a discovery that could lead to an entirely new category of microbiome therapies. 💪 Muscle power predicts survival better than strength — Mayo Clinic Proceedings research shows explosive muscle power has a nearly 7x mortality differential between lowest and highest performers in older women.